PHG / Koninklijke Philips N.V. - Depositary Receipt (Common Stock) - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

Koninklijke Philips NV - إيصال الإيداع (الأسهم العادية)
US ˙ NYSE ˙ US5004723038

الإحصائيات الأساسية
CIK 313216
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Koninklijke Philips N.V. - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
July 29, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 29, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 29, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Prinses Irenest

June 5, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 5, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its c

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 5, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Prinses Irenestr

June 4, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 4, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its c

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 4, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Prinses Irenestr

May 28, 2025 EX-1.01

Standard Smelter Name

Philips Conflict Minerals Report This Conflict Minerals Report for Koninklijke Philips N.

May 28, 2025 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into Eng

SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into English) The Netherlands 001-05146-01 None (State or other jurisdiction of Incorporation or organization) (Commission File Number) (IRS Employer Ident

May 16, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 16, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its c

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 16, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Prinses Irenestr

May 9, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 9, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its ch

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 9, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

May 6, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 6, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its ch

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 6, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

March 24, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 24, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 24, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

February 21, 2025 EX-12.B

EX-12.B

Exhibit 12 (b) Certification I, C.M. Hanneman, certify that: 1.I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under

February 21, 2025 EX-12.A

EX-12.A

Exhibit 12 (a) Certification I, R.W.O. Jakobs, certify that: 1.I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under

February 21, 2025 EX-4.F

RELATIONSHIP AGREEMENT

Exhibit 4 (f) RELATIONSHIP AGREEMENT Between Koninklijke Philips N.V. and EXOR N.V. Dated 13 August 2023 Contents Clause 1 Definitions and construction 2 Terms of Relationship and support 3 Philips Supervisory Board composition 3.1 Appointment and dismissal 3.2 Nomination of the Exor Nominee 3.3 Conflict of interest 3.4 Expiry of nomination right 3.5 Resignation Exor Nominee 3.6 Dismissal Exor Nom

February 21, 2025 EX-99.1

Annual Report 2024 Impact with care PDF/printed version This document is the PDF/printed version of the 2024 Annual Report of Royal Philips and has been prepared for ease of use. The 2024 Annual Report was made publicly available pursuant to section

Annual Report 2024 Impact with care PDF/printed version This document is the PDF/printed version of the 2024 Annual Report of Royal Philips and has been prepared for ease of use.

February 21, 2025 EX-11

Philips Information Classification: public Printed copies are uncontrolled unless authenticated

Philips Insider Trading Rules Philips Insider Trading Rules February 2025 Purpose and scope Insider trading happens when someone trades securities (such as shares) based on price sensitive information that is not publicly available (‘inside information’), which is illegal.

February 21, 2025 EX-4.G

ATTACHMENTS. [***] INDICATES THAT INFORMATION HAS BEEN EXCLUDED.

CERTAIN IDENTIFIED ATTACHMENTS HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THEY ARE NOT MATERIAL.

February 21, 2025 EX-99.2

Press Release February 21, 2025 Philips publishes its Annual Report 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2024. Philips’ Annual Report 2024 will

Press Release February 21, 2025 Philips publishes its Annual Report 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2024.

February 21, 2025 EX-15.A

Consent of Independent Registered Public Accounting Firm

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 21, 2025 20-F

As filed with the Securities and Exchange Commission on 21 February 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F (Mark one) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE

As filed with the Securities and Exchange Commission on 21 February 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 21, 2025 EX-13.B

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 21, 2025 EX-2.B

SONIAi-pLBD x ni

Exhibit 2 (b) KONINKLIJKE PHILIPS N.V. AS ISSUER AND CITICORP TRUSTEE COMPANY LIMITED AS TRUSTEE AMENDED AND RESTATED TRUST DEED RELATING TO A €10,000,000,000 EURO MEDIUM TERM NOTE PROGRAMME CONTENTS 1. Definitions and Interpretation 2. Amount and Issue of the Notes 3. Covenant to Repay 4. The Notes 5. Covenant to Comply with the Trust Deed 6. Covenants by the Issuer 7. Waivers, Modifications, Sub

February 21, 2025 EX-97

I. BACKGROUND

Exhibit 97 CLAWBACK POLICY: RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION I.

February 21, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 21, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 21, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 21, 2025 EX-15.B

EY Accountants B.V.

EY Accountants B.V. Cross Towers, Antonio Vivaldistraat 150 1083 HP Amsterdam, Netherlands Postbus 7883 1008 AB Amsterdam, Netherlands Tel: +31 88 407 10 00 Fax: +31 88 407 10 05 ey.com February 21, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 United States Commissioners: We have read the statements of Philips included in chapter “10.1.6 Annual financial statem

February 21, 2025 EX-4.B

The following contract is the services contract of Ms C.M. Hanneman containing terms and conditions for the provision of services and other arrangements that apply with effect from June 1, 2024 as member of the Executive Committee and, subject to app

Exhibit 4 (b) Services contract between the Company and Ms C.M. Hanneman The following contract is the services contract of Ms C.M. Hanneman containing terms and conditions for the provision of services and other arrangements that apply with effect from June 1, 2024 as member of the Executive Committee and, subject to appointment by the Annual Meeting of Shareholders, as of October 1, 2024 as memb

February 21, 2025 EX-13.A

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 19, 2025 6-K/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 19, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified i

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 19, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner

February 19, 2025 6-K

Quarterly Report 2024 - Q4

Quarterly Report 2024 - Q4 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 19, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation

February 19, 2025 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 19, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 19, 2025 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

October 28, 2024 6-K

KONINKLIJKE PHILIPS N.V. Judgements and estimates Q3 2024 Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world Philips performance Performance per segment Forward-looki

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 28, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

September 3, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 September 3, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

August 30, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 30, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cent

August 23, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 23, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cent

August 5, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 5, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

July 29, 2024 6-K

KONINKLIJKE PHILIPS N.V. Subsequent events Q2 2024 Philips delivers strong order intake growth in the second quarter, margin improvement and sales growth; reiterates full-year outlook Philips performance Performance per segment Reconciliation of non-

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 29, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

June 25, 2024 SC 13D/A

AR:PHG / Koninklijke Philips N.V. - Depositary Receipt (Common Stock) / Exor N.V. - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Koninklijke Philips NV (Name of Issuer) Ordinary shares, par value €0.20 per share (Title of Class of Securities) None (CUSIP Number) Jeff Hendrickson, Esq. Allen Overy Shearman Sterling LLP One Bishops Square London E1 6AD United Kingdom (Name

June 25, 2024 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d826824dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a statement on Schedule 13D (including any and all amendments thereto) with respect to the ordinary shares, with par value €0.20 per share of Koninklijke Philips NV and further agree to the fi

June 20, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 20, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

May 28, 2024 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into Eng

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into English) The Netherlands 001-05146-01 None (State or other jurisdiction of Incorporation or organization) (Commission File Number) (IRS Employer Identifi

May 28, 2024 EX-1.01

4

Exhibit 1.01 Philips Conflict Minerals Report This Conflict Minerals Report for Koninklijke Philips N.V. (hereafter ‘’Royal Philips’’, “Philips”, or “our”) covers the reporting period from January 1, 2023 to December 31, 2023, and has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934. This Conflict Minerals Report is filed as Exhibit 1.01 to Phi

May 24, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 24, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

May 16, 2024 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d841370dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a statement on Schedule 13D (including any and all amendments thereto) with respect to the ordinary shares, with par value €0.20 per share of Koninklijke Philips NV and further agree to the fi

May 16, 2024 SC 13D/A

NL:INPHI / Koninklijke Philips N.V. / Exor N.V. - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Koninklijke Philips NV (Name of Issuer) Ordinary shares, par value €0.20 per share (Title of Class of Securities) None (CUSIP Number) Jeff Hendrickson, Esq. Allen Overy Shearman Sterling LLP One Bishops Square London E1 6AD United Kingdom (Name

May 15, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 15, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

May 14, 2024 EX-4.9

Global Umbrella Long-Term Incentive Plan For the members of the Executive Committee (excluding Board of Management)

Exhibit 4.9 Global Umbrella Long-Term Incentive Plan For the members of the Executive Committee (excluding Board of Management) Under this Global Umbrella Long-Term Incentive Plan, different types of LTI’s (as defined herein) may be granted to the members of the Executive Committee and any other eligible individuals from time to time. Any LTI so granted shall be governed by (i) the terms and condi

May 14, 2024 EX-4.8

Global Umbrella Long-Term Incentive Plan For members of the Board of Management

Exhibit 4.8 Global Umbrella Long-Term Incentive Plan For members of the Board of Management Under this Global Umbrella Long-Term Incentive Plan, LTI’s (as defined herein) may be granted to the members of the Board of Management from time to time, in accordance with and subject to the remuneration policy and/or the long-term incentive plan provisions adopted by the General Meeting and applicable at

May 14, 2024 EX-4.10

Global Umbrella Long-Term Incentive Plan For (non-)executives (excluding Executive Committee)

Exhibit 4.10 Global Umbrella Long-Term Incentive Plan For (non-)executives (excluding Executive Committee) Under this Global Umbrella Long-Term Incentive Plan, different types of LTI’s (as defined herein) may be granted to eligible employees and any other eligible individuals from time to time. Any LTI so granted shall be governed by (i) the terms and conditions outlined in this Plan; (ii) a separ

May 14, 2024 S-8 POS

As filed with the Securities and Exchange Commission on May 14, 2024

As filed with the Securities and Exchange Commission on May 14, 2024 Registration No.

May 8, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 8, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

April 29, 2024 6-K

KONINKLIJKE PHILIPS N.V. Q1 2024 Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion Philips performance Perfo

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 29, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 22, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 22, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

February 28, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 28, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 20, 2024 EX-97

Exhibit 97

Exhibit 97 CLAWBACK POLICY: RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION I.

February 20, 2024 EX-2.B

Exhibit 2 (b)

Exhibit 2 (b) KONINKLIJKE PHILIPS N.V. AS ISSUER AND CITICORP TRUSTEE COMPANY LIMITED AS TRUSTEE AMENDED AND RESTATED TRUST DEED RELATING TO A €10,000,000,000 EURO MEDIUM TERM NOTE PROGRAMME CONTENTS 1. Definitions and Interpretation 2. Amount and Issue of the Notes 3. Covenant to Repay 4. The Notes 5. Covenant to Comply with the Trust Deed 6. Covenants by the Issuer 7. Waivers, Modifications, Sub

February 20, 2024 EX-4.B

Exhibit 4 (b)

Exhibit 4 (b) Services contract between the Company and Mr A. Bhattacharya The following contract is the services contract of Mr A. Bhattacharya, containing terms and conditions for the provision of services and other arrangements that apply with effect from May 9, 2023 (“the Commencement Date”) as member of the Board of Management of Royal Philips (“Koninklijke Philips N.V.”, hereinafter also ref

February 20, 2024 EX-12.B

Exhibit 12 (b)

Exhibit 12 (b) Certification I, A. Bhattacharya, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 20, 2024 EX-99

EX-99

Press information February 20, 2024 Philips publishes its Annual Report 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2023.

February 20, 2024 6-K

KONINKLIJKE PHILIPS N.V. Exhibit index

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 20, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 20, 2024 EX-99

EX-99

PDF/printed version This document is the PDF/printed version of the 2023 Annual Report of Royal Philips and has been prepared for ease of use.

February 20, 2024 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 20, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 20, 2024 EX-15.A

Exhibit 15 (a)

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 20, 2024 EX-13.B

Exhibit 13 (b)

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 20, 2024 20-F

Contents 1Introduction 2Forward-looking statements 3Form 20-F cross reference table 4Message from the CEO 5Board of Management and Executive Committee 6Strategy and Businesses 7Financial performance 8Environmental, Social and Governance 9Risk managem

As filed with the Securities and Exchange Commission on February 20, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 20, 2024 EX-13.A

Exhibit 13 (a)

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 20, 2024 EX-12.A

Exhibit 12 (a)

Exhibit 12 (a) Certification I, R.W.O. Jakobs, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances unde

February 20, 2024 EX-4.F

Exhibit 4 (f)

Exhibit 4 (f) RELATIONSHIP AGREEMENT Between Koninklijke Philips N.V. and EXOR N.V. Dated 13 August 2023 Contents Clause 1 Definitions and construction 2 Terms of Relationship and support 3 Philips Supervisory Board composition 3.1 Appointment and dismissal 3.2 Nomination of the Exor Nominee 3.3 Conflict of interest 3.4 Expiry of nomination right 3.5 Resignation Exor Nominee 3.6 Dismissal Exor Nom

January 29, 2024 6-K

KONINKLIJKE PHILIPS N.V. Q4 2023 Philips delivers strong full-year results; agrees with FDA on terms of consent decree focused on Philips Respironics in the US Fourth-quarter highlights Performance per segment Proposed dividend distribution Full-year

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 29, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

December 20, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 19, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

October 23, 2023 6-K

KONINKLIJKE PHILIPS N.V. Judgements and estimates Q3 2023 Philips delivers strong sales growth, profitability and cash flow; raises full-year outlook Philips performance Performance per segment Forward-looking statements and other important informati

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 23, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

September 7, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 September 7, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

August 23, 2023 EX-99.3

VWAP Share Purchase Transaction on Koninklijke Philips N.V.

EX-99.3 4 d500180dex993.htm EX-99.3 Exhibit 99.3 EXECUTION VERSION Goldman Sachs Bank Europe SE Taunusanlage 9-10, D-60329, Frankfurt am Main, Germany Opening Transaction 13 August 2023 Reference No. as separately notified Customer Account No. 066188178 Exor N.V. Gustav Mahlerplein 25 1082 MS Amsterdam The Netherlands Attention: Guido de Boer, Florence Hinnen and Maite Labairu-Trenchs Dear Sir/ Ma

August 23, 2023 EX-99.4

13 AUGUST 2023 EXOR N.V. (as Chargor) GOLDMAN SACHS BANK EUROPE SE (as Chargee) GOLDMAN SACHS INTERNATIONAL (as Custodian) SECURITY DEED 99 Bishopsgate London EC2M 3XF United Kingdom Tel: +44.20.7710.1000

EX-99.4 5 d500180dex994.htm EX-99.4 Exhibit 99.4 EXECUTION VERSION 13 AUGUST 2023 EXOR N.V. (as Chargor) and GOLDMAN SACHS BANK EUROPE SE (as Chargee) GOLDMAN SACHS INTERNATIONAL (as Custodian) SECURITY DEED 99 Bishopsgate London EC2M 3XF United Kingdom Tel: +44.20.7710.1000 www.lw.com 1 CONTENTS Clause Page 1. INTERPRETATION 3 2. COVENANT TO PAY 7 3. CREATION OF SECURITY 8 4. FURTHER ASSURANCE 8

August 23, 2023 EX-99.2

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

EX-99.2 3 d500180dex992.htm EX-99.2 Exhibit 99.2 RELATIONSHIP AGREEMENT Between Koninklijke Philips N.V. And EXOR N.V. Dated 13 August 2023 Contents Clause Page 1 DEFINITIONS AND CONSTRUCTION 5 2 TERMS OF RELATIONSHIP AND SUPPORT 5 3 PHILIPS SUPERVISORY BOARD COMPOSITION 5 3.1 Appointment and dismissal 5 3.2 Nomination of the Exor Nominee 5 3.3 Conflict of interest 7 3.4 Expiry of nomination right

August 23, 2023 SC 13D

PHG / Koninklijke Philips N.V. - ADR / Exor N.V. - SC 13D Activist Investment

SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Koninklijke Philips NV (Name of Issuer) Ordinary shares, par value €0.20 per share (Title of Class of Securities) None (CUSIP Number) Jeff Hendrickson, Esq. Allen & Overy LLP One Bishops Square London E1 6AD United Kingdom (Name, Address and Teleph

August 23, 2023 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d500180dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a statement on Schedule 13D (including any and all amendments thereto) with respect to the ordinary shares, with par value €0.20 per share of Koninklijke Philips NV and further agree to the fi

August 23, 2023 EX-99.5

Custody Agreement Professional Clients

EX-99.5 6 d500180dex995.htm EX-99.5 Exhibit 99.5 5th JULY 2023 EXOR N.V. GUSTAV MAHLERPLEIN 25A, AMSTERDAM, 1082MS NETHERLANDS Custody Agreement Professional Clients Execution Page These Terms of Business (“Terms”) are dated: 5th JULY 2023 Between: Goldman Sachs International (“GS”)1; and EXOR N.V. a company incorporated in NETHERLANDS, whose registered office is at GUSTAV MAHLERPLEIN 25A, AMSTERD

August 14, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 14, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cent

July 24, 2023 6-K

KONINKLIJKE PHILIPS N.V. Q2 2023 Philips delivers improved operational performance driven by sales growth and focus on execution Philips performance Performance per segment Reconciliation of non-IFRS information Philips statistics Forward-looking sta

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 24, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

June 15, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 14, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

May 22, 2023 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into Eng

SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into English) The Netherlands 001-05146-01 None (State or other jurisdiction of Incorporation or organization) (Commission File Number) (IRS Employer Ident

May 22, 2023 EX-1.01

Smelter ID

EX-1.01 Exhibit 1.01 Philips Conflict Minerals Report This Conflict Minerals Report for Koninklijke Philips N.V. (hereafter ‘’Royal Philips’’, “Philips”, or “our”) covers the reporting period from January 1, 2022 to December 31, 2022, and has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934. This Conflict Minerals Report is filed as Exhibit 1.0

May 17, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

6-K 1 phg-20230517.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 17, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organiz

May 10, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 9, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

April 24, 2023 6-K

KONINKLIJKE PHILIPS N.V. Q1 2023 Philips delivers solid operational performance as supply chain improves and actions to enhance execution start to take effect Philips performance Performance per segment Forward-looking statements and other important

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 24, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 24, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 24, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

February 24, 2023 EX-13.A

Exhibit 13 (a)

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 24, 2023 EX-13.B

Exhibit 13 (b)

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 24, 2023 20-F/A

EXPLANATORY NOTE Contents 1Introduction 2Forward-looking statements 3Form 20-F cross reference table 4Message from the CEO 5Board of Management and Executive Committee 6Strategy and Businesses 7Financial performance 8Environmental, Social and Governa

As filed with the Securities and Exchange Commission on February 24, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 24, 2023 EX-12.B

Exhibit 12 (b)

Exhibit 12 (b) Certification I, A. Bhattacharya, certify that: 1. I have reviewed this Annual Report on Form 20-F, as amended by this Amendment No.1, of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements ma

February 24, 2023 EX-15.A

Exhibit 15 (a)

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 24, 2023 EX-12.A

Exhibit 12 (a)

Exhibit 12 (a) Certification I, R.W.O. Jakobs, certify that: 1. I have reviewed this Annual Report on Form 20-F, as amended by this Amendment No.1, of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made

February 21, 2023 EX-12.A

Exhibit 12 (a)

Exhibit 12 (a) Certification I, R.W.O. Jakobs, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances unde

February 21, 2023 EX-4.A

Exhibit 4 (a)

Exhibit 4 (a) Services contract between the company and Mr R.W.O Jakobs The following contract is the services contract of Mr R.W.O Jakobs, containing terms and conditions for the provision of services and other arrangements that apply with effect from October 15, 2022 (“the Commencement Date”) as member of the Board of Management of Royal Philips (“Koninklijke Philips N.V.”, hereinafter also refe

February 21, 2023 EX-4.6

Amended and Restated Philips North America Nonqualified Stock Purchase Plan.

EX-4.6 Exhibit 4.6 Philips North America Nonqualified Stock Purchase Plan (as amended and restated as of October 24, 2022) 1. General 1.1 Plan Name. Philips North America Nonqualified Stock Purchase Plan. 1.2 Effective Date. Amended and restated effective October 24, 2022. 2. Definitions 2.1 “Administrator”: A third party appointed by the Committee to provide administrative services for the Plan.

February 21, 2023 EX-13.A

Exhibit 13 (a)

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 21, 2023 EX-4.7

Global Philips Stock Option Plan for eligible (non-)executives.

EX-4.7 Exhibit 4.7 Group HRM / CoE Rewards Global Philips Stock Option Plan for eligible (non-)executives Version February 2023 Group HRM/CoE Rewards TERMS AND CONDITIONS OF GLOBAL PHILIPS STOCK OPTION Plan Article 1 Definitions In this Global Philips Stock Option Plan the following definitions shall apply: 1. Business Day : any day on which Euronext Amsterdam is open for business. 2. Divestiture

February 21, 2023 EX-15.A

Exhibit 15 (a)

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 21, 2023 20-F

Contents 1Introduction 2Forward-looking statements 3Form 20-F cross reference table 4Message from the CEO 5Board of Management and Executive Committee 6Strategy and Businesses 7Financial performance 8Environmental, Social and Governance 9Risk managem

As filed with the Securities and Exchange Commission on February 21, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 21, 2023 EX-12.B

Exhibit 12 (b)

Exhibit 12 (b) Certification I, A. Bhattacharya, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 21, 2023 S-8 POS

As filed with the Securities and Exchange Commission on February 21, 2023

S-8 POS As filed with the Securities and Exchange Commission on February 21, 2023 Registration No.

February 21, 2023 EX-13.B

Exhibit 13 (b)

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 21, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 21, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

January 30, 2023 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 30, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 30, 2023 6-K

KONINKLIJKE PHILIPS N.V. Q4 2022 Philips sees some improvement in Q4 2022 and takes firm actions to address operational challenges in an uncertain environment Fourth-quarter highlights Performance per segment Proposed dividend distribution Full-year

6-K 1 phg-20221231.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 30, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or org

October 24, 2022 11-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

11-K Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark one) ☒ Annual Report Pursuant to Section 15 (d) of the Securities Exchange Act of 1934 For the fiscal year ended July 31, 2022 OR ☐ Transition Report Pursuant to Section 15 (d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number: 001-05146-01 PHILIPS NORTH A

October 24, 2022 6-K

KONINKLIJKE PHILIPS N.V. Judgements and estimates Q3 2022 Philips’ Q3 performance impacted by operational and supply challenges; company is taking immediate actions to restore performance Philips performance Performance per segment Forward-looking st

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 24, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

October 12, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 12, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

September 30, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 September 30, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner C

August 18, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 18, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cent

August 16, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 16, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cent

July 25, 2022 6-K

KONINKLIJKE PHILIPS N.V. Q2 2022 Philips' performance impacted by headwinds; order book strength and improving component supplies expected to deliver growth and profitability improvement from second half of 2022 onwards Philips performance Performanc

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 25, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

July 5, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 05, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

June 13, 2022 CORRESP

Amstelplein 2 | 1096 BC Amsterdam | The Netherlands

United States Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F.

June 7, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 07, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

May 25, 2022 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into Eng

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into English) The Netherlands 001-05146-01 None (State or other jurisdiction of Incorporation or organization) (Commission File Number) (IRS Employer Identifi

May 25, 2022 EX-1.01

Smelter ID

Exhibit 1.01 Philips Conflict Minerals Report This Conflict Minerals Report for Koninklijke Philips N.V. (hereafter ?Royal Philips??, ?Philips?, or ?our?) covers the reporting period from January 1, 2021 to December 31, 2021, and has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934. This Conflict Minerals Report is filed as Exhibit 1.01 to Phil

May 10, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 10, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

May 6, 2022 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 6, 2022 Commission File No.: 001-05146-01 KONINKLIJKE PHILIPS N.V. (Exact name of

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 6, 2022 Commission File No.: 001-05146-01 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation

May 6, 2022 EX-99.2

Koninklijke Philips N.V. Announces Tender Results of Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

Exhibit 99.2 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL May 6, 2022 Koninklijke Philips N.V. Announces Tender Results of Any and All Tender Offer for Certain Outstanding USD-Denominated Notes Amsterdam, The Netherlands ? Koninklijke Philips N.V. (?Royal Philips? o

May 6, 2022 EX-99.1

Koninklijke Philips N.V. Announces Pricing Terms of Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

Exhibit 99.1 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL May 5, 2022 Koninklijke Philips N.V. Announces Pricing Terms of Any and All Tender Offer for Certain Outstanding USD-Denominated Notes Amsterdam, The Netherlands ? Koninklijke Philips N.V. (?Royal Philips? or

April 28, 2022 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 28, 2022 Commission File No.: 001-05146-01 KONINKLIJKE PHILIPS N.V. (Exact name

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 28, 2022 Commission File No.: 001-05146-01 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporati

April 28, 2022 EX-99.2

Koninklijke Philips N.V. Announces Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

Exhibit 99.2 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL April 28, 2022 Koninklijke Philips N.V. Announces Any and All Tender Offer for Certain Outstanding USD-Denominated Notes Amsterdam, The Netherlands ? Koninklijke Philips N.V. (?Royal Philips? or the ?Company?

April 28, 2022 EX-99.1

Press Information

Exhibit 99.1 Press Information April 28, 2022 THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL, OR ANY SOLICITATION OF AN OFFER TO PURCHASE, ANY SECURITIES OF PHILIPS. Philips launches offering of Green and Sustainability Innovation Notes and a Series of Liability Management Transactions Amsterdam, the Netherlands ? Royal

April 25, 2022 6-K

KONINKLIJKE PHILIPS N.V. Q1 2022 Philips delivers Q1 sales of EUR 3.9 billion, with good demand driving 5% comparable order intake growth Philips performance Performance per segment Forward-looking statements and other important information Condensed

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 25, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

February 22, 2022 EX-13.B

Exhibit 13 (b)

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 22, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 22, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 22, 2022 EX-13.A

Exhibit 13 (a)

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 22, 2022 20-F

Contents 1Introduction 2Forward-looking statements 3Form 20-F cross reference table 4Message from the CEO 5Board of Management and Executive Committee 6Strategy and Businesses 7Financial performance 8Environmental, Social and Governance 9Risk managem

As filed with the Securities and Exchange Commission on February 22, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 22, 2022 EX-4.C

Exhibit 4 (c)

Exhibit 4 (c) Services contract between the Company and Mr M.J. van Ginneken The following contract is the services contract of Mr M.J. van Ginneken, containing terms and conditions for the provision of services and other arrangements that apply with effect from May 6, 2021 (the ?Commencement Date?), subject to his re-appointment on such date as member of the Board of Management of Koninklijke Phi

February 22, 2022 EX-15.A

Exhibit 15 (a)

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 22, 2022 EX-12.B

Exhibit 12 (b)

Exhibit 12 (b) Certification I, A. Bhattacharya, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 22, 2022 EX-12.A

Exhibit 12 (a)

Exhibit 12 (a) Certification I, F.A. van Houten, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

January 24, 2022 6-K

KONINKLIJKE PHILIPS N.V. Q4 2021 Philips delivers Q4 sales of EUR 4.9 billion and income from continuing operations of EUR 139 million; Adjusted EBITA margin amounts to 13.1%, and operating cash flow is EUR 720 million; good demand drives mid-single-

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 24, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 18, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 18, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 12, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 12, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 10, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 10, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 3, 2022 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 3, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cent

December 30, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 30, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

December 28, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 28, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

December 17, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 17, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

December 13, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 13, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

December 6, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 06, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

November 29, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 November 29, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

November 22, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 November 22, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

November 15, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 November 15, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

November 15, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

6-K 1 phg-20211115.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 November 15, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or or

November 8, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 November 8, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

October 29, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 29, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

October 28, 2021 11-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark one) ? Annual Report Pursuant to Section 15 (d) of the Securities Exchange Act of 1934 For the fiscal year ended July 31, 2021 OR ? Transition Report Pursuant to Section 15 (d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number: 001-05146-01 PHILIPS NORTH AMERIC

October 18, 2021 6-K

KONINKLIJKE PHILIPS N.V. Q3 2021 Philips delivers Q3 sales of EUR 4.2 billion, with a 7.6% comparable sales decline due to headwinds; income from continuing operations increases to EUR 442 million, and Adjusted EBITA margin amounts to 12.3%. Philips

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 18, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

October 7, 2021 SC 13G

GLEO / Galileo Acquisition Corp / KONINKLIJKE PHILIPS NV - SC 13G Passive Investment

SC 13G 1 d218985dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* Under the Securities Exchange Act of 1934 Shapeways Holdings, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 81947T102 (CUSIP Number) September 29, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate b

July 26, 2021 6-K

KONINKLIJKE PHILIPS N.V. Q2 2021 Philips delivers Q2 sales of EUR 4.2 billion, with 9% comparable sales growth; net income amounts to EUR 153 million and Adjusted EBITA margin improves 280 basis points to 12.6%; company announces EUR 1.5 billion shar

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 26, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

June 14, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 14, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

June 8, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

6-K 1 phg-20210608.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 8, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organiz

May 27, 2021 EX-1.01

Smelter ID

Exhibit 1.01 Philips Conflict Minerals Report This Conflict Minerals Report for Koninklijke Philips N.V. (hereafter ??Royal Philips??, ?Philips?, or ?our?) covers the reporting period from January 1, 2020 to December 31, 2020, and has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934. This Conflict Minerals Report is filed as Exhibit 1.01 to Phi

May 27, 2021 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into Eng

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant?s name into English) The Netherlands 001-05146-01 None (State or other jurisdiction of Incorporation or organization) (Commission File Number) (IRS Employer Identifi

May 20, 2021 6-K

KONINKLIJKE PHILIPS N.V. Press information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 20, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

May 7, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 7, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

April 26, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 26, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 25, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 25, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 25, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 25, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

February 23, 2021 EX-4

Exhibit 4 (d)

Exhibit 4 (d) Global Philips Performance Share Plan - For the Board of Management TERMS AND CONDITIONS OF GLOBAL PHILIPS PERFORMANCE SHARE PLAN Article 1 Definitions In this Global Philips Performance Share Plan the following definitions shall apply: 1.

February 23, 2021 EX-4.5

Global Philips Performance Share Plan applicable to the Executive Committee (excluding Board of Management) of Koninklijke Philips N.V.

Exhibit 4.5 Group HRM/CoE Rewards Global Philips Performance Share Plan For the Executive Committee (excluding Board of Management) Version May 2020 Group HRM/CoE Rewards TERMS AND CONDITIONS OF GLOBAL PHILIPS PERFORMANCE SHARE PLAN Article 1 Definitions In this Global Philips Performance Share Plan the following definitions shall apply: 1. Award : the conditional right granted to eligible individ

February 23, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 23, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 23, 2021 EX-12

Exhibit 12 (b)

Exhibit 12 (b) Certification I, A. Bhattacharya, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 23, 2021 EX-13

Exhibit 13 (a)

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 23, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 23, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant?s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 23, 2021 EX-12

Exhibit 12 (a)

Exhibit 12 (a) Certification I, F.A. van Houten, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 23, 2021 EX-13

Exhibit 13 (b)

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 23, 2021 EX-15

Exhibit 15 (a)

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 23, 2021 EX-4.3

Global Philips Performance Share Plan applicable to non-executives (excluding Executive Committee) of Koninklijke Philips N.V.

Exhibit 4.3 Group HRM/CoE Rewards Global Philips Performance Share Plan For (non-)executives (excluding Executive Committee) Version May 2020 Group HRM/CoE Rewards TERMS AND CONDITIONS OF GLOBAL PHILIPS PERFORMANCE SHARE PLAN Article 1 Definitions In this Global Philips Performance Share Plan the following definitions shall apply: 1. Award : the conditional right granted to eligible individuals to

February 23, 2021 S-8 POS

- S-8 POS

As filed with the Securities and Exchange Commission on February 23, 2021 Registration No.

February 23, 2021 20-F

-

As filed with the Securities and Exchange Commission on February 23, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 9, 2021 EX-99.(A)(5)(XXIV)

Press Information

EX-99.(a)(5)(xxiv) Exhibit (a)(5)(xxiv) Press Information February 9, 2021 Philips successfully completes tender offer for BioTelemetry, Inc. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has successfully completed its previously announced tender offer (the “Offer”) to purchase all outstanding shares of BioTelemetry

February 9, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 9, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

February 9, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 9, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

February 9, 2021 SC TO-T/A

- SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 6) BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

February 4, 2021 SC TO-T/A

- SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 5) BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

February 3, 2021 SC 13G/A

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* KONINKLIJKE PHILIPS N.V. (Name of Issuer) Common Stock (Title of Class of Securities) N7637U112 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th

February 1, 2021 SC TO-T/A

- SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 4) BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

February 1, 2021 EX-99.(I)

Reactive statement

EX-(i) Exhibit (i) Reactive statement Philips reactive statement following Long-term Holter (LTH) monitoring reimbursement update by Novitas Solutions February 1, 2021 Philips is reviewing the reimbursement rates for certain Long-term Holter (LTH) monitoring services that were published on January 29, 2021 by Novitas Solutions, a Medicare Administrative Contractor (MAC).

January 25, 2021 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 25, 2021 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 20, 2021 SC TO-T/A

- SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 3) BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

January 7, 2021 SC TO-T/A

- SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

January 4, 2021 SC TO-T/A

- SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

December 23, 2020 EX-99.(A)(1)(VI)

This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). The Offer (as defined below) is made solely by the Offer to Purchase (as defined below) and the related Letter of Transmittal (as defi

EX-99.(a)(1)(vi) Exhibit (a)(1)(vi) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below). The Offer (as defined below) is made solely by the Offer to Purchase (as defined below) and the related Letter of Transmittal (as defined below) and any amendments or supplements thereto. The Offer is not being made to (and no tenders will be accep

December 23, 2020 EX-99.(A)(1)(IV)

Offer To Purchase For Cash All Outstanding Shares of Common Stock BIOTELEMETRY, INC. $72.00 Net per Share DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

EX-99.(a)(1)(iv) Exhibit (a)(1)(iv) Offer To Purchase For Cash All Outstanding Shares of Common Stock of BIOTELEMETRY, INC. at $72.00 Net per Share by DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK TIME, ON FEBRUARY 9, 2021 (ONE MINUTE AFTER

December 23, 2020 EX-99.(D)(2)

[Signature page follows]

EX-99.(d)(2) Exhibit (d)(2) GUARANTEE Koninklijke Philips N.V., a corporation organized under the laws of the Netherlands (the “Guarantor”), hereby irrevocably and unconditionally guarantees to BioTelemetry, Inc., a Delaware corporation, (the “Company”), the full and timely performance by Philips Holding USA Inc., a Delaware corporation (“Parent”), and Davies Merger Sub, Inc., a Delaware corporati

December 23, 2020 EX-99.(A)(1)(I)

Offer to Purchase for Cash All Outstanding Shares of Common Stock BIOTELEMETRY, INC. $72.00 Net Per Share DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V.

EX-99.(a)(1)(i) Table of Contents Exhibit (a)(1)(i) Offer to Purchase for Cash All Outstanding Shares of Common Stock of BIOTELEMETRY, INC. at $72.00 Net Per Share by DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK TIME, ON FEBRUARY 9, 2021 (

December 23, 2020 SC TO-T

- SC TO-T

SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. (Names of Filing Pe

December 23, 2020 EX-99.(A)(1)(III)

NOTICE OF GUARANTEED DELIVERY For Tender of All Outstanding Shares of Common Stock BIOTELEMETRY, INC. $72.00 Net per Share Pursuant to the Offer to Purchase dated December 23, 2020 DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING

EX-99.(a)(1)(iii) Exhibit (a)(1)(iii) NOTICE OF GUARANTEED DELIVERY For Tender of All Outstanding Shares of Common Stock of BIOTELEMETRY, INC. at $72.00 Net per Share Pursuant to the Offer to Purchase dated December 23, 2020 by DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. THE OFFER AND WITHDRAWAL RIGHTS WILL E

December 23, 2020 EX-99.(A)(1)(II)

LETTER OF TRANSMITTAL To Tender Shares of Common Stock BIOTELEMETRY, INC. $72.00 Net Per Share Pursuant to the Offer to Purchase dated December 23, 2020 DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned su

EX-99.(a)(1)(ii) Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL To Tender Shares of Common Stock of BIOTELEMETRY, INC. at $72.00 Net Per Share Pursuant to the Offer to Purchase dated December 23, 2020 by DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW Y

December 23, 2020 EX-99.(A)(1)(V)

Offer To Purchase For Cash All Outstanding Shares of Common Stock BIOTELEMETRY, INC. $72.00 Net per Share Pursuant to the Offer to Purchase dated December 23, 2020 DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a whol

EX-99.(a)(1)(v) Exhibit (a)(1)(v) Offer To Purchase For Cash All Outstanding Shares of Common Stock of BIOTELEMETRY, INC. at $72.00 Net per Share Pursuant to the Offer to Purchase dated December 23, 2020 by DAVIES MERGER SUB, INC., a wholly owned subsidiary of PHILIPS HOLDING USA INC., a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIG

December 23, 2020 EX-99.(D)(3)

PRIVATE AND CONFIDENTIAL October 23, 2020

EX-99.(d)(3) Exhibit (d)(3) PRIVATE AND CONFIDENTIAL October 23, 2020 Koninklijke Philips N.V. Amsetelplein 2 1096 Amsterdam The Netherlands Attention: Frans van Houten Chief Executive Officer CONFIDENTIALITY AGREEMENT Ladies and Gentlemen: Koninklijke Philips N.V. (“Recipient”) has expressed an interest in exploring the possibility of a negotiated transaction involving (the “Possible Transaction”

December 22, 2020 SC TO-C

- SC TO-C

SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. (Names of Filing Persons (Offerors)) Co

December 22, 2020 EX-99.1

Page 1 of 15

EX-99.1 Exhibit 99.1 Joe Capper: Hello, everyone. Welcome to our first town hall with Philips. Today I’m going to introduce you to a few of the people who will guide us during the coming period now that we’ve signed the agreement, and in a few months, when we officially close the transaction. Joe Capper: First, let me walk you through the agenda. Joining me from BioTelemetry is Jason Herpel. On th

December 21, 2020 EX-99.9

Acquisition to boost our patient care management solutions

EX-99.9 Exhibit 99.9 Acquisition to boost our patient care management solutions We have signed an agreement to acquire BioTelemetry, the leading provider of remote cardiac diagnostics and monitoring – a strong fit with our strategy to transform the delivery of care along the health continuum with integrated solutions. “The acquisition of BioTelemetry fits perfectly with our strategy to be a leadin

December 21, 2020 EX-99.7

December xx, 2020

EX-99.7 Exhibit 99.7 December xx, 2020 Dear [Insert First Name or ‘Philips Customers’], As one of our most valued Philips customers, I want to personally inform you of an exciting strategic development in our business. Today, Philips announced that it signed an agreement indicating its intention to acquire BioTelemetry to expand our global leadership in patient care management solutions for the ho

December 21, 2020 EX-99.14

CONFIDENTIAL – UNDER EMBARGO

EX-99.14 Exhibit 99.14 CONFIDENTIAL – UNDER EMBARGO Dear Connected Care Leadership Team: I am excited to share with you that Philips just signed an agreement to acquire BioTelemetry, Inc., a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. Shortly, we will issue a press release and I will share this email wi

December 21, 2020 EX-99.10

Having trouble reading our message? Click here to view the web version

EX-99.10 Exhibit 99.10 From: Harpster, Noah Sent: Friday, December 18, 2020 12:33 PM To: Harpster, Noah Subject: A Message from Vitor Rocha: BioTelemetry Acquisition Having trouble reading our message? Click here to view the web version Dear NA team, As you may have seen, Philips has signed an agreement to acquire BioTelemetry, Inc., a leading remote cardiac diagnostics and monitoring company that

December 21, 2020 SC TO-C

- SC TO-C

SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. (Names of Filing Persons (Offerors)) Co

December 21, 2020 EX-99.2

1

EX-99.2 Exhibit 99.2 CONFIDENTIAL – 18122020FINAL LEANDRO: Thank you and good morning, ladies and gentlemen. Welcome to today’s conference call to update you on our agreement to acquire BioTelemetry Inc. We appreciate that you could join our call on such short notice. I am here with our CEO, Frans van Houten, our CFO, Abhijit Bhattacharya, and the Business Leader for Connected Care, Roy Jakobs. Ou

December 21, 2020 SC TO-C

- SC TO-C

SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. (Names of Filing Persons (Offerors)) Co

December 21, 2020 EX-99.8

© Koninklijke Philips N.V., 2020. All rights reserved. Philips values and respects your privacy. Read more about our Privacy notice.

EX-99.8 Exhibit 99.8 Dear Connected Care Colleagues, I am excited to share with you that we signed an agreement with BioTelemetry to expand our global leadership in patient care management solutions for the hospital and the home. The acquisition is a strong fit with Philips’ strategy to transform the delivery of healthcare: combination of Philips’ leading patient care management position in the ho

December 21, 2020 EX-99.18

CONFIDENTIAL – UNDER EMBARGO

EX-99.18 Exhibit 99.18 CONFIDENTIAL – UNDER EMBARGO Dear CC Global BM&S Leaders, I am excited to share with you that Philips just signed an agreement to acquire BioTelemetry, Inc., a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. BioTelemetry provides remote cardiac monitoring, centralized core laboratory

December 21, 2020 EX-99.5

.@Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry. Read more:

EX-99.5 Exhibit 99.5 Tweet: .@Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry. Read more: LinkedIn: Philips will acquire BioTelemetry Inc., a leading provider of remote cardiac diagnostics and monitoring services. By combining Philips’ leading patient monitoring position in the hospital with BioTelemetry’s

December 21, 2020 EX-99.16

Dear Connected Care Leaders,

EX-99.16 Exhibit 99.16 Dear Connected Care Leaders, As you may know, we have signed an agreement to acquire BioTelemetry, Inc., a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. BioTelemetry provides remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose mo

December 21, 2020 EX-99.15

Dear BioTelemetry diligence / BioTelemetry integration team,

EX-99.15 Exhibit 99.15 Dear BioTelemetry diligence / BioTelemetry integration team, To follow on the announcement of the pending acquisition of BioTelemetry, please find enclosed some important details and guidelines for the coming period until we officially close the deal. Closure is expected around the first quarter of 2021. Feel free to deploy these guidelines in your own teams. • Until the clo

December 21, 2020 EX-99.17

CONFIDENTIAL – UNDER EMBARGO

EX-99.17 Exhibit 99.17 CONFIDENTIAL – UNDER EMBARGO Dear NAM leadership team, I am excited to share with you that Philips just signed an agreement to acquire BioTelemetry, Inc., a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. BioTelemetry provides remote cardiac monitoring, centralized core laboratory ser

December 21, 2020 EX-99.13

1

EX-99.13 Exhibit 99.13 Talking Points: Leadership Team for calls with Philips Employees What was announced… • WHAT WILL BE ANNOUNCED DECEMBER 18, 2020 (8:15AM CET) o Today, Philips announced that we have entered into an agreement to acquire BioTelemetry. This is just the signing of an agreement to acquire; the transaction has not closed; we expect the transaction to close in the first quarter of 2

December 21, 2020 EX-99.1

Agenda 1. Welcome 2. Introducing Roy Jakobs About Philips 3. About Connected Care within Philips 4. Merging our Strengths 5. How we do this, together 6. Q&A 7. Close Roy Jakobs Executive Vice President and Chief Business Leader for the Connected Care

EX-99.1 Stronger together: Philips and BioTelemetry, Inc. Exhibit 99.1 Agenda 1. Welcome 2. Introducing Roy Jakobs About Philips 3. About Connected Care within Philips 4. Merging our Strengths 5. How we do this, together 6. Q&A 7. Close Roy Jakobs Executive Vice President and Chief Business Leader for the Connected Care businesses of Royal Philips; member of the Royal Philips Executive Committee A

December 21, 2020 EX-99.11

Talking Points: Calls with Customers,

EX-99.11 Exhibit 99.11 Talking Points: Calls with Customers, Suppliers, Distributors, KOLs… • Philips has signed an agreement to acquire BioTelemetry, a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. • BioTelemetry provides remote cardiac monitoring, centralized core laboratory services for clinical trials

December 21, 2020 EX-99.12

1

EX-99.12 Exhibit 99.12 BioTelemetry: FAQs About the announcement What was announced? What does this mean? On December 18, 2020, Philips signed an agreement to acquire BioTelemetry. At the close of the transaction, it will form a new business in the Connected Care cluster, reporting to Roy Jakobs, Chief Business Leader, Connected Care, Philips. This acquisition will be an important enhancement to P

December 21, 2020 EX-99.6

Email: Philips broadcast / BioTelemetry Acquisition News from Frans & Roy

EX-99.6 Exhibit 99.6 Email: Philips broadcast / BioTelemetry Acquisition News from Frans & Roy Subject line: Growing our Connected Care business with acquisition of BioTelemetry Dear [name], We are excited that, late yesterday evening Eastern Time, we signed an agreement to acquire BioTelemetry Inc., a leading remote cardiac diagnostics and monitoring company in the U.S. that monitors over one mil

December 18, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 December 18, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

December 18, 2020 EX-99.2

1

EX-99.2 Exhibit 99.2 Dear BioTelemetry Team, Today has been quite an exciting day! With this morning’s announcement of Philips’ intent to acquire BioTelemetry, I look forward to our teams combining forces to expand our leadership position in connected care! Together, we become the global leader in patient care management solutions for the hospital and the home. Philips is a leading health technolo

December 18, 2020 SC TO-C

- SC TO-C

SC TO-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BIOTELEMETRY, INC. (Name of Subject Company (Issuer)) DAVIES MERGER SUB, INC. a wholly owned subsidiary of PHILIPS HOLDING USA INC. a wholly owned subsidiary of KONINKLIJKE PHILIPS N.V. (Names of Filing Persons (Offerors)) Co

December 18, 2020 EX-99.1

Press Information

EX-99.1 Exhibit 99.1 Press Information December 18, 2020 Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry, Inc. • Philips to acquire BioTelemetry, Inc. for USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion) • Acquisition is a strong fit with Philips’ strategy to trans

October 27, 2020 11-K

- 11-K

11-K Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K (Mark one) ☒ Annual Report Pursuant to Section 15 (d) of the Securities Exchange Act of 1934 For the fiscal year ended July 31, 2020 OR ☐ Transition Report Pursuant to Section 15 (d) of the Securities Exchange Act of 1934 For the transaction period from to Commission file number: 001-05146-01 PHILIPS NORTH A

October 19, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 October 19, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

July 20, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 20, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

July 7, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 7, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

July 2, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 2, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

June 25, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 June 25, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

June 25, 2020 CORRESP

-

CORRESP United States Securities and Exchange Commission Division of Corporation Finance, Office of Manufacturing 100 F.

May 26, 2020 SD

- SD

SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT KONINKLIJKE PHILIPS N.V. (Exact name of the Registrant as specified in its charter) ROYAL PHILIPS (Translation of Registrant’s name into English) The Netherlands 001-05146-01 None (State or other jurisdiction of Incorporation or organization) (Commission File Number) (IRS Employer Ident

May 26, 2020 EX-1.01

1

EX-1.01 Exhibit 1.01 Philips Conflict Minerals Report This Conflict Minerals Report for Koninklijke Philips N.V. (hereafter ‘’Royal Philips’’, “Philips”, or “our”) covers the reporting period from January 1, 2019 to December 31, 2019, and has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934. This Conflict Minerals Report is filed as Exhibit 1.0

May 8, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 8, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center,

April 30, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 30, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

April 24, 2020 6-K

Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 24, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

April 20, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 20, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 30, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 30, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 26, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 26, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 23, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 23, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 23, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 23, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 18, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 18, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cente

March 9, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 9, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

March 2, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 March 2, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center

February 25, 2020 EX-13

Exhibit 13 (a)

Exhibit 13 (a) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 25, 2020 EX-13

Exhibit 13 (b)

Exhibit 13 (b) Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Koninklijke Philips N.

February 25, 2020 EX-12

Exhibit 12 (b)

Exhibit 12 (b) Certification I, A. Bhattacharya, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 25, 2020 EX-4

Exhibit 4 (b)

Exhibit 4 (b) Services contract between the Company and Mr A. Bhattacharya The following contract is the services contract of Mr A. Bhattacharya, containing terms and conditions for the provision of services and other arrangements that apply with effect from May 9, 2019 (“the Commencement Date”) as member of the Board of Management of Royal Philips (“Koninklijke Philips N.V.”, hereinafter also ref

February 25, 2020 EX-2

Exhibit 2

Exhibit 2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT As of 31 December 2019 Koninklijke Philips N.

February 25, 2020 EX-15

Exhibit 15 (a)

Exhibit 15 (a) Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.

February 25, 2020 EX-12

Exhibit 12 (a)

Exhibit 12 (a) Certification I, F.A. van Houten, certify that: 1. I have reviewed this Annual Report on Form 20-F of Koninklijke Philips N.V., a company incorporated under the laws of The Netherlands; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances un

February 25, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 25, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Ce

February 25, 2020 EX-4

Exhibit 4 (a)

Exhibit 4 (a) Services contract between the Company and Mr F.A. van Houten The following contract is the services contract of Mr F.A. van Houten, containing terms and conditions for the provision of services and other arrangements that apply with effect from May 9, 2019 (“the Commencement Date”) as member of the Board of Management of Royal Philips (“Koninklijke Philips N.V.”, hereinafter also ref

February 25, 2020 20-F

PHG / Koninklijke Philips N.V 20-F - -

As filed with the Securities and Exchange Commission on February 25, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

January 28, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 28, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 28, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 28, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

January 27, 2020 6-K

PHG / Koninklijke Philips N.V 6-K - Current Report of Foreign Issuer -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 January 27, 2020 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Cen

Other Listings
DE:PHIA € ٢٣٫٦٠
GB:0A2M
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista